Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Carparts.Com Inc (PRTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Carparts.Com Inc — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Carparts.Com Inc trades at $7.75 (market cap $63.04M). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 82.2× Carparts.Com Inc's market cap, and Oruka Therapeutics Inc. Common Stock is more actively traded (490,798 versus 22,319). Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Carparts.Com Inc for 45 Days on average.
| ORKA | PRTS | |
|---|---|---|
Market Cap | $5.18B | $63.04M |
Volume | 490,798 | 22,319 |
Sector | Health | Consumer Cyclical |
52-Week High | $113.08 | $10.00 |
52-Week Low | $26.19 | $3.88 |
Typical Hold Time | 0 Days | 45 Days |
Enterprise Value | $4.31B | $76.01M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CarParts.com (PRTS) trades at $7.54, down 13.03% today, reflecting ongoing investor concerns despite recent earnings beats. The stock shows weak technical momentum with negative price action, while fundamentally the company faces profitability challenges with a -9.22% net margin in 2025, though revenue decline appears to be moderating. Analyst sentiment remains cautiously optimistic with 60% buy ratings, but negative cash flow and declining revenue trends present headwinds.
The outlook remains challenging with persistent losses and negative cash flow, though valuation metrics like P/S of 0.11 suggest potential undervaluation. Key risks include continued revenue contraction and inability to achieve profitability, while opportunities lie in the company's data-driven competitive positioning and potential turnaround execution. Investors should weigh the attractive valuation against fundamental deterioration.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Carparts.Com Inc
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Read more on PRTS →
